David Lane. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntigens, Neoplasm/immunologyAntineoplastic Agents/administration & dosageAntineoplastic Combined Chemotherapy Protocols/immunologyAntineoplastic Combined Chemotherapy Protocols/therapeutic useCamptothecin/administration & dosageCamptothecin/analogs & derivativesCamptothecin/immunologyCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/immunologyCell Line, TumorDrug Delivery Systems/methodsDrug DesignFemaleHumansImmunotherapy/methodsIrinotecanMembrane Proteins/immunologyMiceMice, NudeTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntigens, NeoplasmAntineoplastic AgentsMembrane ProteinsIrinotecanCamptothecin
Year: 2006 PMID: 16465160 DOI: 10.1038/nbt0206-163
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908